Medical treatment of renal cancer: new horizons

por Greef, Basma, Eisen, Tim
Publicado 2016

Renal cell carcinoma and the use of sorafenib

por Larkin, James MG, Eisen, Tim
Publicado 2006

Identification of low penetrance alleles for lung cancer: The GEnetic Lung CAncer Predisposition Study (GELCAPS)

por Eisen, Tim, Matakidou, Athena, Houlston, Richard
Publicado 2008

Naptumomab Estafenatox: Targeted Immunotherapy with a Novel Immunotoxin

por Eisen, Tim, Hedlund, Gunnar, Forsberg, Göran, Hawkins, Robert
Publicado 2014

Adjuvant Therapy in Renal Cell Carcinoma—Past, Present, and Future()

por Janowitz, Tobias, Welsh, Sarah J., Zaki, Kamarul, Mulders, Peter, Eisen, Tim
Publicado 2013

Dose escalation of axitinib on disease progression as a strategy in the treatment of metastatic renal cell carcinoma

por Doherty, Gary Joseph, Lynskey, Deirdre, Matakidou, Athena, Fife, Kate, Eisen, Tim
Publicado 2018

An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma

por Gossage, Lucy, Pires, Douglas E. V., Olivera-Nappa, Álvaro, Asenjo, Juan, Bycroft, Mark, Blundell, Tom L., Eisen, Tim
Publicado 2014

Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK

por Hawkins, Robert, Fife, Kate, Hurst, Michael, Wang, Meng, Naicker, Niroshini, Nolasco, Sarah, Eisen, Tim, Matakidou, Athena, Gordon, Jason
Publicado 2020

The CHRNA5–A3–B4 Gene Cluster and Smoking: From Discovery to Therapeutics

por Lassi, Glenda, Taylor, Amy E., Timpson, Nicholas J., Kenny, Paul J., Mather, Robert J., Eisen, Tim, Munafò, Marcus R.
Publicado 2016

Efficacy of tivozanib treatment after sorafenib in patients with advanced renal cell carcinoma: crossover of a phase 3 study

por Molina, Ana M., Hutson, Thomas E., Nosov, Dmitry, Tomczak, Piotr, Lipatov, Oleg, Sternberg, Cora N., Motzer, Robert, Eisen, Tim
Publicado 2018

Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial

por Eisen, Tim, Oudard, Stéphane, Szczylik, Cezary, Gravis, Gwenaelle, Heinzer, Hans, Middleton, Richard, Cihon, Frank, Anderson, Sibyl, Shah, Sonalee, Bukowski, Ronald, Escudier, Bernard
Publicado 2008

The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data

por Gill, Andrew B., Anandappa, Gayathri, Patterson, Andrew J., Priest, Andrew N., Graves, Martin J., Janowitz, Tobias, Jodrell, Duncan I., Eisen, Tim, Lomas, David J.
Publicado 2015

A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma

por Syafruddin, Saiful E., Rodrigues, Paulo, Vojtasova, Erika, Patel, Saroor A., Zaini, M. Nazhif, Burge, Johanna, Warren, Anne Y., Stewart, Grant D., Eisen, Tim, Bihary, Dóra, Samarajiwa, Shamith A., Vanharanta, Sakari
Publicado 2019

What Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection of Intermediate- or High-Risk Renal Cell Carcinoma? Clinical Investigators’ Preferences in t...

por Lawrence, Nicola J., Martin, Andrew, Davis, Ian D., Troon, Simon, Sengupta, Shomik, Hovey, Elizabeth, Coskinas, Xanthi, Kaplan, Richard, Smith, Benjamin, Ritchie, Alastair, Meade, Angela, Eisen, Tim, Blinman, Prunella, Stockler, Martin R.
Publicado 2018

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma

por Harmon, Charles S., DePrimo, Samuel E., Figlin, Robert A., Hudes, Gary R., Hutson, Thomas E., Michaelson, M. Dror, Négrier, Sylvie, Kim, Sindy T., Huang, Xin, Williams, J. Andrew, Eisen, Tim, Motzer, Robert J.
Publicado 2013

Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma

por Aeppli, Stefanie, Eboulet, Eric Innocents, Eisen, Tim, Escudier, Bernard, Fischer, Stefanie, Larkin, James, Gruenwald, Viktor, McDermott, David, Oldenburg, Jan, Omlin, Aurelius, Porta, Camillo, Rini, Brian, Schmidinger, Manuela, Sternberg, Cora, Rothermundt, Christian
Publicado 2020

The Efficacy of Sunitinib Treatment of Renal Cancer Cells Is Associated with the Protein PHAX In Vitro

por Al-Lamki, Rafia S., Hudson, Nicholas J., Bradley, John R., Warren, Anne Y., Eisen, Tim, Welsh, Sarah J., Riddick, Antony C. P., O’Mahony, Fiach C., Turnbull, Arran, Powles, Thomas, Reverter, Antonio, Harrison, David J., Stewart, Grant D.
Publicado 2020

The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospecti...

por Klatte, Tobias, Gallagher, Kevin M., Afferi, Luca, Volpe, Alessandro, Kroeger, Nils, Ribback, Silvia, McNeill, Alan, Riddick, Antony C. P., Armitage, James N., ‘Aho, Tevita F., Eisen, Tim, Fife, Kate, Bex, Axel, Pantuck, Allan J., Stewart, Grant D.
Publicado 2019

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer

por Tsui, Dana Wai Yi, Murtaza, Muhammed, Wong, Alvin Seng Cheong, Rueda, Oscar M, Smith, Christopher G, Chandrananda, Dineika, Soo, Ross A, Lim, Hong Liang, Goh, Boon Cher, Caldas, Carlos, Forshew, Tim, Gale, Davina, Liu, Wei, Morris, James, Marass, Francesco, Eisen, Tim, Chin, Tan Min, Rosenfeld, Nitzan
Publicado 2018

External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer

por Oza, Bhavna, Eisen, Tim, Frangou, Eleni, Stewart, Grant D., Bex, Axel, Ritchie, Alastair W.S., Kaplan, Rick, Smith, Benjamin, Davis, Ian D., Stockler, Martin R., Albiges, Laurence, Escudier, Bernard, Larkin, James, Joniau, Steven, Hancock, Barry, Hermann, Gregers G., Bellmunt, Joaquim, Parmar, Mahesh K.B., Royston, Patrick, Meade, Angela
Publicado 2022